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Objectives: Despite the burden of venous
thromboembolism (VTE) among surgical patients on
health systems in Australia, data on VTE incidence and
its variation within Australia are lacking. We aim to
explore VTE and subsequent mortality rates, trends
and variations across Australian acute public
hospitals.
Setting: A large retrospective cohort study using all
elective surgical patients in 82 acute public hospitals
during 2002–2009 in New South Wales, Australia.
Participants: Patients underwent elective surgery
within 2 days of admission, aged between 18 and
90 years, and who were not transferred to another
acute care facility; 4 362 624 patients were included.
Outcome measures: VTE incidents were identified
by secondary diagnostic codes. Poisson mixed
models were used to derive adjusted incidence rates
and rate ratios (IRR).
Results: 2/1000 patients developed postoperative
VTE. VTE increased by 30% (IRR=1.30, CI 1.19 to
1.42) over the study period. Differences in the VTE
rates, trends between hospital peer groups and
between hospitals with the highest and those with the
lowest rates were significant (between-hospital
variation). Smaller hospitals, accommodated in two
peer groups, had the lowest overall VTE rates
(IRR=0.56:0.33 to 0.95; IRR=0.37:0.23 to 0.61) and
exhibited a greater increase (64% and 237% vs 19%)
overtime and greater between-hospital variations
compared to larger hospitals (IRR=8.64:6.23 to 11.98;
IRR=8.92:5.49 to 14.49 vs IRR=3.70:3.32 to 4.12).
Mortality among patients with postoperative VTE was
8% and remained stable overtime. No differences in
post-VTE death rates and trends were seen between
hospital groups; however, larger hospitals exhibited
less between-hospital variations (IRR=1.78:1.30 to
2.44) compared to small hospitals (IRR>23).
Hospitals performed differently in prevention versus
treatment of postoperative VTE.
Conclusions: VTE incidence is increasing and there
is large variation between-hospital and within-hospital
peer groups suggesting a varied compliance with VTE
preventative strategies and the potential for targeted
interventions and quality improvement opportunities.
INTRODUCTION
Venous thromboembolism (VTE), comprised
of deep-vein thrombosis (DVT) and pulmon-
ary embolism (PE), can cause long-term
comorbidities or death1 2 and incur a signiﬁ-
cant ﬁnancial burden on healthcare
systems.3 4 It accounts for nearly 10% of all
deaths in USA5 6 and Australian hospitals,7 8
and is among the top ﬁve most common
causes of hospital-related deaths in both
countries.3 9 However, VTE is also the most
common preventable cause of hospital
deaths.10–13 A signiﬁcant decrease in VTE
incidents has been reported where efﬁca-
cious and cost-effective treatments (ie,
pharmacological and mechanical prophy-
laxis) were used for medical as well as surgi-
cal patients.1 12 14–19 Accordingly, several
evidence-based VTE prevention and treat-
ment guidelines were developed1 9 20 and
related measures were adopted among
quality of care indices for accreditation,
quality improvement and benchmarking pur-
poses.21–23
Strengths and limitations of this study
▪ This study benefited from a large cohort design
within the largest health jurisdiction in Australia.
▪ Employment of standardised and broadly-applied
venous thromboembolism (VTE) measures facili-
tated local and international comparisons and
benchmarking.
▪ Demonstration of trends and variations in VTE
measures reflected effectiveness of systematic
interventions and revealed opportunities for
further improvement and actions at local and
regional levels.
▪ This study was limited to VTE incidence among
elective surgical patients. Analysis of all patient
populations may provide addition insight.
▪ The obtained rates may have underestimated due
to possible coding discrepancies.
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The Agency for Healthcare Research and Quality
(AHRQ) listed postoperative VTE complication (VTE inci-
dence following surgery) and subsequent death as a com-
ponent of failure-to-rescue (FTR) among patient safety
indicators (PSI #12 and PSI #4-2, respectively), which are
routinely being monitored and publically reported.23 24
Reports showed that postoperative VTE incidence rates
have nearly halved in USA hospitals in recent years24 25
and post-VTE mortality rates declined by a third within a
decade since the mid-90s.26 These rate decreases may be,
in part, due to the implementation of postoperative VTE
prevention protocols,27 however, substantial variation in
postoperative VTE incidence rates was also evident among
US hospitals.25 Although patients’ case mix and surgery
types may play a role in such differences,6 28 29 the vari-
ation of VTE incidence among the same type of hospitals
overtime and within the group may reﬂect the success of
quality improvement interventions and demonstrate the
potential for further development.30 31
Few Australian studies have reported VTE incidence,3 8 32
and the measures of VTE used in these studies varied
making comparison difﬁcult. Consequently, we employed
the internationally-recognised AHRQ measures for post-
operative VTE, and subsequent mortality, to explore the
trend of the incidence rates and their variations among
admitted surgical patients in acute public hospitals across
New South Wales (NSW), Australia (2002–2009).
METHODS
Data source and study population
NSW is the largest health jurisdiction in Australia with
approximately 497 healthcare facilities and a population
of over seven million people. We used records from the
NSW Admitted Patient Data Collection (APDC) data-
base, which includes all admitted patient services pro-
vided by NSW public and private healthcare facilities.
The APDC includes information on patient demograph-
ics, medical conditions and procedures, hospital
characteristics, and separations (discharges, transfers
and deaths) from all public and private hospitals (as
well as day procedure centres) in NSW. The medical
records for each episode of care in the APDC were
assigned with codes based on the International
Statistical Classiﬁcation of Diseases and Related Health
Problems, Tenth Revision, Australian Modiﬁcation
(ICD-10-AM) 4th edition.33 Of admissions at 497 health-
care facilities across NSW between 1 January 2002 to 31
December 2009, we included all 82 NSW acute public
hospitals (9 221 128 admissions; 57.4%) in our study.
Two children’s hospitals and one other hospital (data
was unavailable) were excluded. We restricted our study
to only elective surgical patients and applied the same
AHRQ inclusion criteria23 for patients who had elective
surgery within 2 days of admission, those criteria being:
patients should be aged between 18 and 90 years (inclu-
sive), and should not have been transferred to another
acute care facility (4 362 624 episodes (47.3%)).
Measures and covariates
Of surgical patients who met AHRQ inclusion criteria
(patients at risk), those who developed VTE were identi-
ﬁed by secondary diagnostic codes (ICD-10-AM) trans-
lated from the AHRQ deﬁnition ICD, Ninth Revision,
Clinical Modiﬁcation (ICD-9-CM) by Victorian
Government Health Information.34 The outcome
measure was termed ‘postoperative VTE’, proposed by
the Australian version of PSIs (AusPSI),35 instead of the
‘perioperative VTE’ term suggested by AHRQ.23 We
used the ‘postoperative VTE’ term since employment of
inclusion criteria (undergoing surgery within 2 days of
admission and secondary diagnosis of VTE) minimised
likelihood of VTE presence on admission or VTE occur-
ance prior to surgery. In combination with discharge
status, patients’ post-VTE outcomes were categorised as
survival or death. VTE and related death rates were pre-
sented as incidences per 1000 admissions within each
year between 2002 and 2009, inclusively.
Two sets of patient-related and hospital-related covari-
ates were considered. Patient demographic variables
included age, gender, country of birth, marital status,
patient socioeconomic status and principle diagnostic
disease groups (the 10 most common) within the study
population. We utilised a postcode-level advantage and dis-
advantage index of Socio-Economic Indices for Areas
(SEIFA) with the lower values indicating more disadvan-
taged areas.36 SEIFA scores were categorised into four
classes (1st quartile (Q1)=most disadvantaged areas and
4th quartile (Q4)=most advantaged areas). The disease
groups were identiﬁed using principle diagnostic codes
(ICD-10-AM) at admissions through the methodology
developed by Quan et al.37 Using relevant procedure codes
from ICD-10-AM (see online supplementary appendix 1),
we deﬁned six major surgical procedures including
coronary-artery bypass graft, abdominal aortic aneurysm
(AAA) repair, total hip replacement, total knee replace-
ment, cholecystectomy and other surgical procedures.
Hospital covariates included the local health district
(metropolitan, rural and regional NSW) and peer group
(A1: principal referral group, usually teaching hospitals;
A3: ungrouped acute; B: major metropolitan and non-
metropolitan; C1: district group 1; and, C2: district
group 2). Hospital peer groups contained similar type
and sized hospitals, ranging from those treating more
than 25 000 acute case-mix weighted separations per
annum in principal referral groups through to treating
2000+ (but less than 5000) acute case-mix weighted
separations per annum in district group 2.38
Statistical analysis
We employed Poisson mixed models to evaluate adjusted
incidence rates and rate ratios for study outcomes after
including all patients and hospital-related characteristics.
A random intercept term was utilised to incorporate any
clustering effect at hospital-level. To investigate the tem-
poral behaviour of the outcomes, calendar years were
entered into the model as indicator variables, with 2002
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as the reference year. A model with the year as a con-
tinuous variable was also examined for linear trends. We
derived hospital peer group and surgery type trends
using interaction effects (year and hospital peer group;
year and surgery type) in separate models. Adjusted inci-
dence rates for speciﬁc years were derived by multiplying
yearly-adjusted risk ratios to the crude risks observed in
the reference year.
We initially examined the Elixhauser and the Charlson
Index comorbidities based on the ICD-10 coding
scheme,37 however, we did not include either of them in
the models given an unexpected drop in the comorbid-
ity index among our study population in recent years
(see online supplementary appendix 2) and also recent
reports that these indices may introduce misleading
results possibly due to geographical variations and biases
in the coding.39–41 To study the variation of outcomes
across hospitals within each hospital group, hospital-
speciﬁc random intercept components were extracted
from Poisson mixed models constructed for each hos-
pital group, then ranked and categorised into ﬁve
classes at 20% incremental quintiles. To obtain adjusted
differences between those with the highest and those
with the lowest VTE incidence, the adjusted classes were
entered into a Poisson model including patient
characteristics covariates. We used Pearson correlation to
assess the association of hospital performances between
VTE and post-VTE deaths, based on the hospital-speciﬁc
random intercepts. All analyses were performed in R
package V.3.0.042 and Stata V.11.0.43
RESULT
Table 1 summarised the study population by outcomes
across hospital and patient characteristics and related
statistics. Of the 4 223 317 (45.8% of all admissions with
no missing information) elective surgical admissions
during 2002–2009 with a median length of stay of 1 day
(the Q1 and the third quartiles (Q3) equal to 1 day),
8451 patients developed either DVT or PE after surgery,
resulting in an incidence rate of 2/1000 surgical patients
with a median length of stay of 11 days (Q1=6 and
Q3=21 days). Among them, 673 (8%) died prior to dis-
charge with a median length of stay of 11 days (Q1=4
and Q3=22 days); 79.6/1000 patients with postoperative
VTE. Compared to women, men tended to have a lower
risk of postoperative VTE (incidence rate ratio (IRR)
=0.91); however, they were more likely to die (IRR=1.19)
following a VTE. Older patients were exposed to higher
risks of VTE and death after surgery. Married patients
and those who were born in Europe (except the UK),
Asia and North Africa experienced a lower risk of post-
operative VTE compared to their counterparts but a
similar risk of post-VTE death.
Patients admitted with malignancy and congestive heart
failure had the highest VTE and hospital mortality rates.
Patients who underwent total knee replacement, AAA
repair and total hip replacement surgeries had higher risk
of VTE, respectively; however, post-VTE mortality was
lower among orthopaedic surgical patients compared to
other procedures. Higher socioeconomic status (quartiles
of SEIFA) of patients was associated with a lower risk of
VTE. There was no difference in mortality for patients res-
iding in advantaged and disadvantaged areas. Patients
from principal referral hospitals were more likely to
acquire VTE in comparison to the patients from district
hospitals (IRR= 0.56 and 0.37 for group 1 and 2 hospitals
respectively). No differences in outcomes were observed
between metropolitan and non-metropolitan hospitals.
Postoperative VTE incidence rates signiﬁcantly
increased over the study period by 30%, from 1.77/1000
patients in 2002 to 2.30 in 2009 (ﬁgure 1). Despite some
ﬂuctuation, all hospital peer groups exhibited similar
increasing trends in postoperative VTE incidence over
the study period after adjustment for patient demo-
graphics (ﬁgure 2), ranging from 19% (2.58 vs 2.17) in
principal referral hospitals to 237% (1.21 vs 0.36) in dis-
trict group 2. Surgery-speciﬁc VTE rates for the ﬁve pro-
cedures exhibited high ﬂuctuations and insigniﬁcant
trends, whereas the other surgery group showed a steady
increasing trend of 38% (3.01 vs 2.18) over the study
period (ﬁgure 3). Post-VTE mortality ﬂuctuated between
68 and 97 cases per 1000 patients over the study period
with no signiﬁcant change after adjusting for confoun-
ders overall (ﬁgure 1) and at hospital peer group level
(ﬁgure 2). Mortality tended to be stable across hospital
peer groups as between-group variation of mortality
reduced over the study period. No surgery-speciﬁc trend
analysis was conducted due to small number of
post-DVT deaths per annum.
The incidence rate ratios between those hospitals
with the lowest, and those with the highest rate, was
larger in VTE related mortality than in VTE and varied
across hospital peer group (table 2). For VTE, the dif-
ference in rate is less than fourfold in the principal
referral and major peer groups (include large hospi-
tals) but at least eightfold in district peer groups
(include small hospitals). Similarly, the difference in
rate is larger in district group 1 and 2 (IRR=23 and 38)
compared to principal referral (IRR=1.7) and major
metropolitan/non-metropolitan hospitals (IRR=15) for
VTE related deaths. The close to signiﬁcant negative
correlation (−0.45, p value=0.057) for principal referral
hospitals implied that hospitals with the highest post-
operative VTE rate tended to have a lower rate of subse-
quent death. In contrast, within district group 2 (0.41),
hospitals with higher VTE rates tended to also have the
highest post-VTE death rates. There were no such associa-
tions within other peer groups.
DISCUSSION
In this large cohort study of elective surgical patients
from all NSW acute public hospitals over an 8-year
period, we found the incidence of VTE to be 2 of 1000
elective surgical admissions, and VTE-associated
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Frequency (%) IR IRR (95% CI) Frequency (%) IR IRR (95% CI)
Sex
Female 2 280 384 (54.00) 4626 (54.74) 2.03 1.00 330 (49.03) 71.34 1.00
Male 1 942 933 (46.00) 3825 (45.26) 1.97 0.90 (0.86 to 0.94)* 343 (50.97) 89.67 1.19 (1.02 to 1.40)†
Age (years)
≥18 and <35 738 382 (17.48) 487 (5.76) 0.66 0.21 (0.19 to 0.23)* 11 (1.63) 22.59 0.20 (0.11 to 0.37)*
≥35 and <55 1 013 921 (24.01) 1308 (15.48) 1.29 0.42 (0.40 to 0.45)* 82 (12.18) 62.69 0.58 (0.45 to 0.74)*
≥55 and <75 1 595 024 (37.77) 3538 (41.86) 2.22 0.66 (0.63 to 0.70)* 290 (43.09) 81.97 0.85 (0.72 to 1.01)
≥75 and <90 875 990 (20.74) 3118 (36.90) 3.56 1.00 290 (43.09) 93.01 1.00
Marital status
Married 2 548 508 (60.34) 4667 (55.22) 1.83 1.00 381 (56.61) 81.64 1.00
Single 1 674 809 (39.66) 3784 (44.78) 2.26 1.16 (1.11 to 1.21)* 292 (43.39) 77.17 1.01 (0.86 to 1.18)
Country of birth
Australia and New Zealand 2 839 135 (67.23) 5858 (69.32) 2.06 1.00 479 (71.17) 81.77 1.00
UK, US and Canada 239 088 (5.66) 645 (7.63) 2.70 1.06 (0.97 to 1.15) 53 (7.88) 82.17 0.95 (0.72 to 1.27)
Non-English Europe 447 239 (10.59) 1046 (12.38) 2.34 0.74 (0.69 to 0.80)* 80 (11.89) 76.48 0.91 (0.71 to 1.16)
North Africa 130 938 (3.10) 139 (1.64) 1.06 0.47 (0.40 to 0.56)* 9 (1.34) 64.75 0.87 (0.45 to 1.70)
Asia 179 725 (4.26) 193 (2.28) 1.07 0.45 (0.39 to 0.52)* 16 (2.38) 82.90 1.09 (0.66 to 1.80)
Others 387 192 (9.17) 570 (6.74) 1.47 0.58 (0.53 to 0.64)* 36 (5.35) 63.16 0.95 (0.67 to 1.35)
Major surgical procedure
AAA repair 1744 (0.04) 26 (0.31) 14.91 1.00 6 (0.89) 230.77 1.00
CABG 10 529 (0.25) 52 (0.62) 4.94 0.37 (0.23 to 0.60)* 7 (1.04) 134.62 0.69 (0.23 to 2.10)
Cholecystectomy 50 145 (1.19) 42 (0.50) 0.84 0.09 (0.05 to 0.15)* 6 (0.89) 142.86 0.70 (0.22 to 2.22)
Total hip replacement 18 771 (0.44) 207 (2.45) 11.03 0.74 (0.49 to 1.11) 4 (0.59) 19.32 0.12 (0.03 to 0.44)*
Total knee replacement 29 428 (0.70) 798 (9.44) 27.12 1.76 (1.19 to 2.61)* 3 (0.45) 3.76 0.03 (0.01 to 0.11)*
Other 4 112 700 (97.38) 7326 (86.69) 1.78 0.17 (0.11 to 0.24)* 647 (96.14) 88.32 0.52 (0.23 to 1.19)
Major principle diagnostic diseases‡
Cardiac arrhythmias 25 953 (0.61) 75 (0.89) 2.89
Chronic pulmonary disease 11 558 (0.27) 69 (0.82) 5.97
Coagulopathy 3908 (0.09) 37 (0.44) 9.47
Congestive heart failure 6765 (0.16) 85 (1.01) 12.56
Diabetes with chronic complication 33 541 (0.79) 79 (0.93) 2.36 – 2 (0.30) 26.67
Malignancy including lymphoma
and leukaemia
150 962 (3.57) 1070 (12.66) 7.09 – 6 (0.89) 86.96
Metastatic solid tumour 19 699 (0.47) 291 (3.44) 14.77 – 2 (0.30) 54.05 –
Peripheral vascular disease 15 993 (0.38) 141 (1.67) 8.82 – 17 (2.53) 200.00 –
Renal failure 1 385 753 (32.81) 42 (0.50) 0.03 – 11 (1.63) 139.24 –
Rheumatoid arthritis/collagen
vascular disease
10 748 (0.25) 40 (0.47) 3.72 – 182 (27.04) 170.09 –
Year – 67 (9.96) 230.24 –
2002 431 184 (10.21) 763 (9.03) 1.77 – 10 (1.49) 70.92 –


































Frequency (%) IR IRR (95% CI) Frequency (%) IR IRR (95% CI)
2004 462 451 (10.95) 878 (10.39) 1.90 – 1 (0.15) 25.00 –
2005 508 097 (12.03) 1038 (12.28) 2.04 1.17 (1.07 to 1.29)* 75 (11.14) 72.25 –
2006 550 688 (13.04) 1062 (12.57) 1.93 1.11 (1.01 to 1.22)† 103 (15.30) 96.99 –
2007 591 973 (14.02) 1223 (14.47) 2.07 1.22 (1.12 to 1.34)* 87 (12.93) 71.14 0.72 (0.52 to 1.01)
2008 607 631 (14.39) 1313 (15.54) 2.16 1.27 (1.16 to 1.38)* 112 (16.64) 85.30 0.90 (0.66 to 1.23)
2009 633 235 (14.99) 1394 (16.50) 2.20 1.30 (1.19 to 1.42)* 113 (16.79) 81.06 0.83 (0.60 to 1.13)
Year-linear trend – – – 1.04 (1.03 to 1.05)* – – 0.98 (0.95 to 1.02)
Quartiles of SEIFA
1st quartile (most disadvantaged) 1 089 833 (25.81) 2308 (27.31) 2.12 1.00 187 (27.79) 81.02 1.00
2nd quartile 1 084 727 (25.68) 1981 (23.44) 1.83 0.88 (0.82 to 0.94)* 169 (25.11) 85.31 0.96 (0.78 to 1.20)
3rd quartile 1 074 283 (25.44) 2088 (24.71) 1.94 0.76 (0.72 to 0.81)* 175 (26.00) 83.81 1.04 (0.84 to 1.30)
4th quartile (most advantaged) 974 474 (23.07) 2074 (24.54) 2.13 0.70 (0.65 to 0.75)* 142 (21.10) 68.47 0.98 (0.77 to 1.26)
Peer hospital groups
Principal referral 2 269 392 (53.73) 5141 (60.83) 2.27 1.00 381 (56.61) 74.11 1.00
Ungrouped acute 133 465 (3.16) 380 (4.50) 2.85 1.20 (0.54 to 2.66) 43 (6.39) 113.16 0.94 (0.37 to 2.39)
Major metrometropolitan and
non-metropolitan
1 140 036 (26.99) 2125 (25.14) 1.86 0.84 (0.54 to 1.31) 183 (27.19) 86.12 0.96 (0.60 to 1.55)
District group 1 346 910 (8.21) 484 (5.73) 1.40 0.56 (0.33 to 0.95)† 42 (6.24) 86.78 0.99 (0.54 to 1.83)
District group 2 333 514 (7.90) 321 (3.80) 0.96 0.37 (0.23 to 0.61)* 24 (3.57) 74.77 0.74 (0.38 to 1.44)
Local health district
Metropolitan 2 720 690 (64.42) 5882 (69.60) 2.16 1.00 430 (63.89) 73.10 1.00
Rural and Regional NSW 1 502 627 (35.58) 2569 (30.40) 1.71 0.74 (0.52 to 1.05) 243 (36.11) 94.59 1.26 (0.82 to 1.92)
Total 4 223 317 8451 2.00 – 673 79.64 –
139 307 (3.2%) cases were excluded due to missing or unknown items.
IR are crude and reported per 1000 patients.
IRR and related CI were obtained using a Poisson mixed model.
*Significant at 1%.
†Significant at 5%.
‡No RR is reported since this characteristic has not been included in the Poisson mixed model.
AAA repair, abdominal aortic aneurysm repair; CABG, coronary artery bypass graft; CI, confidence interval; IR, Incidence rates; IRR, incidence rate ratios; NSW, New South Wales; SEIFA,




























mortality to be 8%. The adjusted incidence of VTE
increased signiﬁcantly over the study period (30%), with
no change in mortality. There were signiﬁcant differ-
ences in incidence of VTE between hospital peer groups
and between hospitals with the lowest and those with the
highest rates. Principal referral hospitals exhibited a
higher overall incidence, but lower intragroup variation
compared to other peer groups. Principal referral hospi-
tals with a higher incidence of VTE also tended to have
a lower VTE-related mortality.
The incidence of postoperative VTE in NSW hospitals
was less than half that of US hospitals within a similar
period (4.5 or more per 1000 patients in 2010 and
prior),25 44 but with a similar VTE-associated mortality (83
vs 79/1000 patients). 25 Based on our ﬁndings, VTE inci-
dence and associated mortality contributes to approxi-
mately 15% and 8% of overall FTR-related incidence and
mortality (13.8 and 140 per 1000 patients, respectively).45 46
Despite the fact that our study and the US study used the
identical measure deﬁned by AHRQ,23 the discrepancies
and coding practices between the USA (ICD-9-CM) and
Australia (ICD-10-AM) may, in part, have contributed to
the difference. It was shown that accuracy of VTE coding
can be improved by the adoption of extended codes devel-
oped in the revised ICD-9-CM. 47
In a recent Organization for Economic and
Co-Operation and Development (OECD) report,
Australia-wide incidence were 0.97 and 1.26/1000
patients in 2009 and 2012 respectively, placing Australia
among three nations (Australia, Slovenia and the USA)
with the highest incidence of approximately 1 per a 1000
surgical patients or more within the last decade.48 Our
observed rates for NSW hospitals was nearly double that
of the OCED provided Australian rates, possibly due to
the fact that we studied only elective surgical patients
from acute public hospitals. Such cross-nations’ reports
provide a platform for health service comparisons and
the study of longitudinal variations. However, internal
and external comparability of OCED results may be
affected by the heterogeneity and biases of the different
nations’ coding systems.
Despite continued poor compliance with VTE preven-
tion guidelines and VTE preventative measures,49–52
postoperative VTE incidence in US hospitals almost
halved between 2007 and 2011.24 44 In Australia, given
the overt gap between evidence and practice of VTE
Figure 1 Adjusted trends of postoperative venous
thromboembolism (VTE) and post-VTE death incidence rates
(per 1000 elective surgical patients and 1000 patients with
postoperative VTE, respectively) over the study period. Rates
were estimated by multiplying incidence rate ratio (obtained
from the Poisson mix model) and crude risk at the reference
year (2002).
Figure 2 Hospital peer
group-specific adjusted trends of
postoperative venous
thromboembolism (VTE) (left
panel) and post-VTE death (right
panel) incidence rates (per 1000
elective surgical patients and
1000 patients with postoperative
VTE, respectively) over the study
period. Rates were estimated by
multiplying incidence rate ratio
(obtained from the Poisson mix
model including an interaction
term for ‘hospital peer
group×year’) and crude risk of the
reference hospital group
(principal referral) at the
reference year (2002).
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prevention protocols,53 54 the National Institute of
Clinical Studies (NICS) launched a VTE prevention pro-
gramme in 85 public and private hospitals across
Australia between 2005 and 2008, which resulted in
increased awareness of and adherence with VTE preven-
tion guidelines.2 55 However, we found an increasing
trend in NSW postoperative VTE incidence rates within
2002–2009, with an approximate 4% annual increase
and total increase of 30%, mostly contributed by the
higher incidence in the smaller hospital peer groups
(237%) compared to the large teaching hospital group
(19%). The reason for this increase is unclear.
Our ﬁnding of a higher incidence of VTE and VTE
associated mortality with increasing age is similar to that
observed by others.29 56–58 Ageing was previously
accepted as a major contributing factor to the increasing
trends in VTE rates for admitted patients in Australian
hospitals.3 However, we have taken into account patient
characteristics including age as well as surgery type and
demonstrated an adjusted increasing trend for surgical
patients, despite the observed decreasing trends in pro-
portions of AAA repair and orthopaedic surgical proce-
dures (see online supplementary appendix 2) known
with high postoperative VTE risks (table 1).1 Notably,
the steadily increasing VTE incidences among patients
who underwent other surgical procedures mainly con-
tributed to the observed overall trend (ﬁgure 3). More
research is required to examine the contributing factors
for such a difference among different surgical proce-
dures. In particular, comorbidity-speciﬁc analysis at hos-





















































































































































































































































































































































































































































































































































































































Figure 3 Surgical procedure-specific adjusted trends of
postoperative venous thromboembolism incidence rates (per
1000 elective surgical patients) over the study period. Rates
were estimated by multiplying incidence rate ratio (obtained from
the Poisson mix model including an interaction term for ‘surgery
type×year’) and crude risk of the reference surgery group
(abdominal aortic aneurysm repair) at the reference year (2002).
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Although other studies suggest gender may not be a
signiﬁcant risk factor for VTE,28 29 59 we found men
were less likely to develop VTE complications, but more
likely to subsequently die. We did not separately explore
DVT and PE incidence and associated deaths between
genders; but our higher mortality risk for men can be
explained by the estimated higher odds of PE (vs DVT,
which has a lower risk of death29 59 for men compared
to women (1.87 vs 1.02 respectively) in Australian hospi-
tals during our study period.3
Variation in the application of VTE prevention guide-
lines and other quality initiatives may have contributed to
the differences in outcomes among the hospitals in our
study. Smaller district 1 and 2 peer group hospitals had a
signiﬁcantly lower VTE incidence rate compared to larger
hospitals in NSW. This was in contrast with other studies,
which showed that larger hospitals have a lower mortality
following major procedures, such as orthopaedic surger-
ies60 61 and postoperative complications such as VTE.62
A possible explanation for this discrepancy is that principal
referral hospitals undertook higher risk patients and surgi-
cal complexity than the smaller district hospitals.
Geographical variations in coding,39–41 underreporting of
VTE due to mis-coding to a more general cardiovascular
item3 63 and high diagnosis likelihood of high risk but
asymptomatic postoperative patients64 may also have con-
tributed to elevated VTE rates in major hospitals. We did
not observe any differences between NSW hospital peer
groups for VTE mortality, neither other studies did for FTR
rates.45 However, we did observe greater variation in VTE
mortality within peer groups comprising smaller sized hos-
pitals in comparison to larger principal referral hospitals.
Our study showed a signiﬁcant performance differ-
ence between hospitals and within each hospital peer
group of the highest and the lowest VTE incidence and
associated mortality. Similarly, the association between
the two outcomes also varied across groups. Smaller hos-
pitals (district groups 1 and 2) exhibited larger differ-
ences in both outcomes, suggesting a greater variability
of patient care practice and outcomes among this group
of hospitals and the greater potential for intervention
aimed at VTE prevention and treatment for this group.
We also noted a positive association between VTE inci-
dence and VTE mortality among smaller size hospital
groups. In contrast, the fact that larger NSW hospitals
tended to have a higher VTE incidence but lower VTE
associated mortality suggests that there may be a
volume–outcome relationship or a greater adherence to
evidence-based prevention and treatment guidelines,
which may explain this better VTE-associated mortality.
Interestingly, if the higher incidence of VTE alone was
used as a measure of failure-to-prevent, these hospitals
may be considered to have performed poorly overall,
despite the better VTE-associated mortality. Conversely,
if the higher incidence rates of VTE were largely due to
patient selection and case-mix, these hospitals could be
considered as better quality hospitals having a lower
FTR rate with better treatment outcomes. Further
investigation into the factors that may explain these dif-
ferences and the ideal reporting measures is warranted.
Our study raised several important policy implications.
First, despite the fact that national and state agencies
had developed evidence-based guidelines, such as the
Clinical Excellence Commission of NSW ‘Medication
Safety’,65 in which VTE prevention practices were pro-
moted and related incidents evaluated, the increasing
incidence of VTE and unchanged VTE mortality ques-
tion the effectiveness of current national policy and
local programmes in reducing VTE incidence and mor-
tality. Second, the development of a systematic local pro-
gramme based on relevant international experience in
successfully reducing VTE rate and its related mortality
needs urgent policy action. Third, the large variability of
VTE rate and its related mortality between and within
different hospital peer groups suggests that there is
room for improvement in the prevention and also in the
treatment of VTE and that VTE still remains a prevent-
able complication. Lastly, as an important indicator of
the quality of care, the level of standardised reporting of
VTE in Australia should be explored.
The strengths of our study are that it is the ﬁrst
population-based observational study across all acute public
hospitals within one (ie, NSW) health region. We used a
standardised measure and presented incidence rates of
VTE and VTE-associated mortality as well, thus enabling
differentiation between the two outcome measures and
allowing for international comparisons. Limitations of our
study include that we speciﬁcally studied only elective surgi-
cal patients according to AHRQ deﬁnitions; whereas the
analyses of all patient populations may provide addition
insight. Future research needs to provide more evidence
on the whole inpatient population. We also may have
under-reported our ﬁndings because of possible coding
discrepancies. Nevertheless, this study reinforced the
importance of developing measures for combating post-
operative VTE, and the continual monitoring and public
reporting of VTE incidence and mortality.2 66
CONCLUSION
The signiﬁcant increase in VTE incidence among surgical
patients over an 8-year period and persisting level of
VTE-associated mortality highlights the need for urgent
policy interventions. The signiﬁcant variation for both
outcomes between, and within, different hospital peer
groups suggests room for improvement in the prevention
and also treatment of VTE. Routine measurement and
disclosure of VTE incidence as well as associated mortality
can provide policymakers, clinicians and researchers with
opportunities to monitor and adjust for performance.
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